These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 1730271
21. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites. Pérez Brandán C, Mesías AC, Parodi C, Cimino RO, Pérez Brandán C, Diosque P, Basombrío MÁ. BMC Infect Dis; 2017 Nov 25; 17(1):732. PubMed ID: 29178839 [Abstract] [Full Text] [Related]
22. Immune response against Trypanosoma cruzi antigens in Cebus apella monkeys. Malchiodi EL, Carbonetto CH, Grana D, Eiguchi de Palmero K, Chiaramonte MG, Falasca CA, Margni RA. Trop Med Parasitol; 1993 Jun 25; 44(2):86-90. PubMed ID: 8367672 [Abstract] [Full Text] [Related]
23. Characterization of antibody isotype responsible for immune clearance in mice infected with Trypanosoma cruzi. Brodskyn CI, da Silva AM, Takehara HA, Mota I. Immunol Lett; 1988 Aug 25; 18(4):255-8. PubMed ID: 3141272 [Abstract] [Full Text] [Related]
24. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice. Hegazy-Hassan W, Zepeda-Escobar JA, Ochoa-García L, Contreras-Ortíz JME, Tenorio-Borroto E, Barbabosa-Pliego A, Aparicio-Burgos JE, Oros-Pantoja R, Rivas-Santiago B, Díaz-Albiter H, Garg NJ, Vázquez-Chagoyán JC. Vaccine; 2019 Jan 07; 37(2):248-257. PubMed ID: 30497833 [Abstract] [Full Text] [Related]
25. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection. dos Santos DM, Talvani A, Guedes PM, Machado-Coelho GL, de Lana M, Bahia MT. Exp Parasitol; 2009 Jan 07; 121(1):8-14. PubMed ID: 18848935 [Abstract] [Full Text] [Related]
26. Chagas' disease: IgG isotypes against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage. Cerban FM, Gea S, Menso E, Vottero-Cima E. Clin Immunol Immunopathol; 1993 Apr 07; 67(1):25-30. PubMed ID: 8443982 [Abstract] [Full Text] [Related]
27. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]. Braun M, de Titto E. Acta Physiol Pharmacol Latinoam; 1985 Apr 07; 35(1):1-47. PubMed ID: 2932884 [Abstract] [Full Text] [Related]
28. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients. Flechas ID, Cuellar A, Cucunubá ZM, Rosas F, Velasco V, Steindel M, Thomas Mdel C, López MC, González JM, Puerta CJ. BMC Infect Dis; 2009 Nov 25; 9():186. PubMed ID: 19939275 [Abstract] [Full Text] [Related]
29. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice. Bryan MA, Guyach SE, Norris KA. PLoS Negl Trop Dis; 2010 Jul 06; 4(7):e733. PubMed ID: 20625554 [Abstract] [Full Text] [Related]
30. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease. Umezawa ES, Shikanai-Yasuda MA, Stolf AM. J Clin Lab Anal; 1996 Jul 06; 10(6):407-13. PubMed ID: 8951611 [Abstract] [Full Text] [Related]
31. Immunological response of Swiss mice to infection with three different strains of Trypanosoma cruzi. Andrade SG, Andrade V, Brodskyn C, Magalhães JB, Netto MB. Ann Trop Med Parasitol; 1985 Aug 06; 79(4):397-407. PubMed ID: 3935064 [Abstract] [Full Text] [Related]
32. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection. Cetron MS, Basilio FP, Moraes AP, Sousa AQ, Paes JN, Kahn SJ, Wener MH, Van Voorhis WC. Am J Trop Med Hyg; 1993 Sep 06; 49(3):370-82. PubMed ID: 8372959 [Abstract] [Full Text] [Related]
33. Trypanosoma cruzi: immune response and functional heart damage induced in mice by the main linear B-cell epitope of parasite ribosomal P proteins. Motrán CC, Cerbán FM, Rivarola W, Iosa D, Vottero de Cima E. Exp Parasitol; 1998 Mar 06; 88(3):223-30. PubMed ID: 9562426 [Abstract] [Full Text] [Related]
34. Identification of antigens of Trypanosoma cruzi which induce antibodies during experimental Chagas' disease. Grögl M, Kuhn RE. J Parasitol; 1985 Apr 06; 71(2):183-91. PubMed ID: 3923183 [Abstract] [Full Text] [Related]
35. Chagas' disease: polyspecificity of antibodies against Trypanosoma cruzi acidic antigens. Ordoñez P, Gea S, Iosa D, Vottero-Cima E. Acta Trop; 1995 May 06; 59(2):93-103. PubMed ID: 7676911 [Abstract] [Full Text] [Related]
36. Alterations in production of immunoglobulin classes and subclasses during experimental Trypanosoma cruzi infection. Jeng GK, Kierszenbaum F. Infect Immun; 1984 Feb 06; 43(2):768-70. PubMed ID: 6420348 [Abstract] [Full Text] [Related]
38. Isotype of antibodies responsible for immune lysis in Trypanosoma cruzi infected mice. Stefani MM, Takehara HA, Mota I. Immunol Lett; 1983 Feb 06; 7(2):91-7. PubMed ID: 6418640 [Abstract] [Full Text] [Related]
39. NK1.1+ cells and T-cell activation in euthymic and thymectomized C57Bl/6 mice during acute Trypanosoma cruzi infection. Cardillo F, Cunha FQ, Tamashiro WM, Russo M, Garcia SB, Mengel J. Scand J Immunol; 2002 Jan 06; 55(1):96-104. PubMed ID: 11841697 [Abstract] [Full Text] [Related]
40. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Marinho CR, D'Império Lima MR, Grisotto MG, Alvarez JM. Infect Immun; 1999 Jan 06; 67(1):308-18. PubMed ID: 9864231 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]